Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
2000 1
2001 1
2002 1
2003 7
2004 3
2005 7
2006 8
2007 12
2008 7
2009 5
2010 6
2011 10
2012 7
2013 4
2014 4
2015 8
2016 7
2017 2
2018 12
2019 10
2020 18
2021 23
2022 27
2023 20
2024 31
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

240 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.
Connolly SJ, Karthikeyan G, Ntsekhe M, Haileamlak A, El Sayed A, El Ghamrawy A, Damasceno A, Avezum A, Dans AML, Gitura B, Hu D, Kamanzi ER, Maklady F, Fana G, Gonzalez-Hermosillo JA, Musuku J, Kazmi K, Zühlke L, Gondwe L, Ma C, Paniagua M, Ogah OS, Molefe-Baikai OJ, Lwabi P, Chillo P, Sharma SK, Cabral TTJ, Tarhuni WM, Benz A, van Eikels M, Krol A, Pattath D, Balasubramanian K, Rangarajan S, Ramasundarahettige C, Mayosi B, Yusuf S; INVICTUS Investigators. Connolly SJ, et al. N Engl J Med. 2022 Sep 15;387(11):978-988. doi: 10.1056/NEJMoa2209051. Epub 2022 Aug 28. N Engl J Med. 2022. PMID: 36036525 Clinical Trial.
Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes.
Pongor LS, Schultz CW, Rinaldi L, Wangsa D, Redon CE, Takahashi N, Fialkoff G, Desai P, Zhang Y, Burkett S, Hermoni N, Vilk N, Gutin J, Gergely R, Zhao Y, Nichols S, Vilimas R, Sciuto L, Graham C, Caravaca JM, Turan S, Tsai-Wei S, Rajapakse VN, Kumar R, Upadhyay D, Kumar S, Kim YS, Roper N, Tran B, Hewitt SM, Kleiner DE, Aladjem MI, Friedman N, Hager GL, Pommier Y, Ried T, Thomas A. Pongor LS, et al. Among authors: upadhyay d. Cancer Discov. 2023 Apr 3;13(4):928-949. doi: 10.1158/2159-8290.CD-22-0796. Cancer Discov. 2023. PMID: 36715552 Free PMC article.
Plasma proteomics of acute tubular injury.
Schmidt IM, Surapaneni AL, Zhao R, Upadhyay D, Yeo WJ, Schlosser P, Huynh C, Srivastava A, Palsson R, Kim T, Stillman IE, Barwinska D, Barasch J, Eadon MT, El-Achkar TM, Henderson J, Moledina DG, Rosas SE, Claudel SE, Verma A, Wen Y, Lindenmayer M, Huber TB, Parikh SV, Shapiro JP, Rovin BH, Stanaway IB, Sathe NA, Bhatraju PK, Coresh J; Kidney Precision Medicine Project; Rhee EP, Grams ME, Waikar SS. Schmidt IM, et al. Among authors: upadhyay d. Nat Commun. 2024 Aug 27;15(1):7368. doi: 10.1038/s41467-024-51304-x. Nat Commun. 2024. PMID: 39191768 Free PMC article.
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.
Abel ML, Takahashi N, Peer C, Redon CE, Nichols S, Vilimas R, Lee MJ, Lee S, Shelat M, Kattappuram R, Sciuto L, Pinkiert D, Graham C, Butcher D, Karim B, Sharma AK, Malin J, Kumar R, Schultz CW, Goyal S, Del Rivero J, Krishnamurthy M, Upadhyay D, Schroeder B, Sissung T, Tyagi M, Kim J, Pommier Y, Aladjem M, Raffeld M, Figg WD, Trepel J, Xi L, Desai P, Thomas A. Abel ML, et al. Among authors: upadhyay d. Clin Cancer Res. 2023 Sep 15;29(18):3603-3611. doi: 10.1158/1078-0432.CCR-23-0536. Clin Cancer Res. 2023. PMID: 37227187 Free PMC article.
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial.
Takahashi N, Hao Z, Villaruz LC, Zhang J, Ruiz J, Petty WJ, Mamdani H, Riess JW, Nieva J, Pachecho JM, Fuld AD, Shum E, Chauhan A, Nichols S, Shimellis H, McGlone J, Sciuto L, Pinkiert D, Graham C, Shelat M, Kattappuram R, Abel M, Schroeder B, Upadhyay D, Krishnamurthy M, Sharma AK, Kumar R, Malin J, Schultz CW, Goyal S, Redon CE, Pommier Y, Aladjem MI, Gore SD, Steinberg SM, Vilimas R, Desai P, Thomas A. Takahashi N, et al. Among authors: upadhyay d. JAMA Oncol. 2023 Dec 1;9(12):1669-1677. doi: 10.1001/jamaoncol.2023.4025. JAMA Oncol. 2023. PMID: 37824137 Free PMC article. Clinical Trial.
Novel azoles with potent antileishmanial activity.
Mathur T, Kumar M, Barman TK, Raj VS, Upadhyay DJ, Verma AK. Mathur T, et al. Among authors: upadhyay dj. Future Microbiol. 2021 Aug;16:871-877. doi: 10.2217/fmb-2020-0320. Epub 2021 Jul 28. Future Microbiol. 2021. PMID: 34318681
IL-23/Th17 Axis: A Potential Therapeutic Target of Psoriasis.
Sharma A, Upadhyay DK, Gupta GD, Narang RK, Rai VK. Sharma A, et al. Among authors: upadhyay dk. Curr Drug Res Rev. 2022;14(1):24-36. doi: 10.2174/2589977513666210707114520. Curr Drug Res Rev. 2022. PMID: 34238181 Review.
The Story of Aldosterone Escape.
Prasad D, Drysch A, Upadhyay D, Neilson EG. Prasad D, et al. Among authors: upadhyay d. J Am Soc Nephrol. 2025 Nov 10. doi: 10.1681/ASN.0000000908. Online ahead of print. J Am Soc Nephrol. 2025. PMID: 41056081
Improving diagnostic performance through feedback: the Diagnosis Learning Cycle.
Fernandez Branson C, Williams M, Chan TM, Graber ML, Lane KP, Grieser S, Landis-Lewis Z, Cooke J, Upadhyay DK, Mondoux S, Singh H, Zwaan L, Friedman C, Olson APJ. Fernandez Branson C, et al. Among authors: upadhyay dk. BMJ Qual Saf. 2021 Dec;30(12):1002-1009. doi: 10.1136/bmjqs-2020-012456. Epub 2021 Aug 20. BMJ Qual Saf. 2021. PMID: 34417335 Free PMC article. Review.
240 results